TransMed7, LLC Announces First Clinical Use of Heron Soft Tissue Biopsy Devices for Commercial Launch
Portola Valley, CA, August 16, 2022 – TransMed7, LLC announced today that the “First in Human” clinical case of the commercial production
News & Announcements
Category: Uncategorized
TransMed7, LLC Announces First Clinical Use of SpeedBird™ Breast Biopsy Devices for Commercial Launch
Portola Valley, CA, August 8, 2022 – TransMed7, LLC announced today that the first clinical cases of the final commercial production version
TransMed7, LLC Announces First Results from Clinical Use of its Vacuum-Assisted, Single Insertion – Multiple Collection (SIMC™) Platform of Breast Biopsy Devices
PHOENIX, AZ, September 22, 2020 – TransMed7, LLC announced today that the first of the vacuum-assisted, Single Insertion – Multiple Collection (SIMC™)
TransMed7, LLC Announces 510(k) Clearance by the U.S. FDA for its Concorde US
(Ultrasound) and Concorde ST (Stereotactic) Soft Tissue Biopsy Device Platform
Portola Valley, CA –TransMed7, LLC announced today that the United States Food and Drug Administration (FDA) has cleared its 510(k) application for the company to market TransMed7’s new Concorde USTM and Concorde STTM soft tissue biopsy devices.